Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-12-27
2005-12-27
Carlson, Karen Cochrane (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S011400, C530S317000, C530S321000
Reexamination Certificate
active
06979671
ABSTRACT:
The present invention relates to a cyclosporin analog of the following formula (I) or its pro-drug or pharmaceutically acceptable salt:In formula I, the formula for residue A is:where X and Y are defined according to the claimed invention the present invention also relates to pharmaceutical compositions comprising pro-drugs or pharmaceutically acceptable salts of the compounds of the present invention and the use thereof for treating an inflammatory or immune disorder in a subject need of such treatment.
REFERENCES:
patent: 4554351 (1985-11-01), Wenger
patent: 4798823 (1989-01-01), Witzel
patent: 5239057 (1993-08-01), Wang et al.
patent: 5356633 (1994-10-01), Woodle et al.
patent: 5427960 (1995-06-01), Wang et al.
patent: 5525590 (1996-06-01), Bollinger et al.
patent: 5643870 (1997-07-01), Boelsterli et al.
patent: 5827706 (1998-10-01), Leitner et al.
patent: 6605593 (2003-08-01), Naicker et al.
patent: 6784156 (2004-08-01), Or et al.
patent: 6809077 (2004-10-01), Or et al.
patent: 2002/0132763 (2002-09-01), Naicker et al.
patent: 2004/0110666 (2004-06-01), Or et al.
patent: 2004/0157768 (2004-08-01), Or et al.
patent: 0 296 122 (1988-12-01), None
patent: 0296122 (1988-12-01), None
patent: WO 99/18120 (1999-04-01), None
patent: WO-99/65933 (1999-12-01), None
patent: WO 99/65933 (1999-12-01), None
patent: WO-00/45834 (2000-08-01), None
Billich et al., Enzymatic Synthesis of CsA, J. Biol. Chem., 262,17258-17259 (1987).
Faulds et al., Cyclosporin: A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Use in Immunoregulatory Disorders, Drugs 46, 953-1040 (1993).
Eckstein Jens Werner
Lazarova Tsvetelina
Or Yat Sun
Carlson Karen Cochrane
Edwards & Angell, LLP.
Enanta Pharmaceuticals, Inc.
Hsi Jeffrey D.
Liu Samuel Wei
LandOfFree
Cyclosporins for the treatment of immune disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclosporins for the treatment of immune disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclosporins for the treatment of immune disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3493910